Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.

Aguiar RC, Chase A, Coulthard S, Macdonald DH, Carapeti M, Reiter A, Sohal J, Lennard A, Goldman JM, Cross NC.

Blood. 1997 Oct 15;90(8):3130-5.

2.

RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).

Panagopoulos I, Isaksson M, Lindvall C, Björkholm M, Ahlgren T, Fioretos T, Heim S, Mitelman F, Johansson B.

Genes Chromosomes Cancer. 2000 Aug;28(4):415-24.

PMID:
10862050
3.

Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.

Liang J, Prouty L, Williams BJ, Dayton MA, Blanchard KL.

Blood. 1998 Sep 15;92(6):2118-22.

4.

Consistent fusion of MOZ and TIF2 in AML with inv(8)(p11q13).

Carapeti M, Aguiar RC, Watmore AE, Goldman JM, Cross NC.

Cancer Genet Cytogenet. 1999 Aug;113(1):70-2.

PMID:
10459350
5.

RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.

Schmidt HH, Strehl S, Thaler D, Strunk D, Sill H, Linkesch W, Jäger U, Sperr W, Greinix HT, König M, Emberger W, Haas OA.

Leukemia. 2004 Jun;18(6):1115-21.

PMID:
15085163
6.

Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16).

Giles RH, Dauwerse JG, Higgins C, Petrij F, Wessels JW, Beverstock GC, Döhner H, Jotterand-Bellomo M, Falkenburg JH, Slater RM, van Ommen GJ, Hagemeijer A, van der Reijden BA, Breuning MH.

Leukemia. 1997 Dec;11(12):2087-96.

PMID:
9447825
7.

Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).

Panagopoulos I, Isaksson M, Lindvall C, Hagemeijer A, Mitelman F, Johansson B.

Genes Chromosomes Cancer. 2003 Jan;36(1):90-8.

PMID:
12461753
8.

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.

Borrow J, Stanton VP Jr, Andresen JM, Becher R, Behm FG, Chaganti RS, Civin CI, Disteche C, Dubé I, Frischauf AM, Horsman D, Mitelman F, Volinia S, Watmore AE, Housman DE.

Nat Genet. 1996 Sep;14(1):33-41.

PMID:
8782817
9.

A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16).

Chaffanet M, Mozziconacci MJ, Fernandez F, Sainty D, Lafage-Pochitaloff M, Birnbaum D, Pébusque MJ.

Genes Chromosomes Cancer. 1999 Oct;26(2):161-5.

PMID:
10469454
10.

MOZ is fused to p300 in an acute monocytic leukemia with t(8;22).

Chaffanet M, Gressin L, Preudhomme C, Soenen-Cornu V, Birnbaum D, Pébusque MJ.

Genes Chromosomes Cancer. 2000 Jun;28(2):138-44.

PMID:
10824998
11.

A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.

Carapeti M, Aguiar RC, Goldman JM, Cross NC.

Blood. 1998 May 1;91(9):3127-33.

12.

Acute myeloid leukemia with inv(8)(p11q13).

Panagopoulos I, Teixeira MR, Micci F, Hammerstrøm J, Isaksson M, Johansson B, Mitelman F, Heim S.

Leuk Lymphoma. 2000 Nov;39(5-6):651-6. Review.

PMID:
11342350
13.

Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11).

Imamura T, Kakazu N, Hibi S, Morimoto A, Fukushima Y, Ijuin I, Hada S, Kitabayashi I, Abe T, Imashuku S.

Genes Chromosomes Cancer. 2003 Apr;36(4):413-9.

PMID:
12619166
14.

Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13).

Panagopoulos I, Fioretos T, Isaksson M, Samuelsson U, Billström R, Strömbeck B, Mitelman F, Johansson B.

Hum Mol Genet. 2001 Feb 15;10(4):395-404.

15.

Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation.

Satake N, Ishida Y, Otoh Y, Hinohara S, Kobayashi H, Sakashita A, Maseki N, Kaneko Y.

Genes Chromosomes Cancer. 1997 Sep;20(1):60-3.

PMID:
9290955
16.

FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia.

Dierlamm J, Stul M, Vranckx H, Michaux L, Weghuis DE, Speleman F, Selleslag D, Kramer MH, Noens LA, Cassiman JJ, Van den Berghe H, Hagemeijer A.

Genes Chromosomes Cancer. 1998 Jun;22(2):87-94. Review.

PMID:
9598794
17.

All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.

Rowley JD, Reshmi S, Sobulo O, Musvee T, Anastasi J, Raimondi S, Schneider NR, Barredo JC, Cantu ES, Schlegelberger B, Behm F, Doggett NA, Borrow J, Zeleznik-Le N.

Blood. 1997 Jul 15;90(2):535-41.

18.

Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5.

Poirel H, Rack K, Delabesse E, Radford-Weiss I, Troussard X, Debert C, Leboeuf D, Bastard C, Picard F, Veil-Buzyn A, Flandrin G, Bernard O, Macintyre E.

Blood. 1996 Mar 15;87(6):2496-505.

19.

Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.

Rozman M, Camós M, Colomer D, Villamor N, Esteve J, Costa D, Carrió A, Aymerich M, Aguilar JL, Domingo A, Solé F, Gomis F, Florensa L, Montserrat E, Campo E.

Genes Chromosomes Cancer. 2004 Jun;40(2):140-5.

PMID:
15101047
20.

A further case of acute myelomonocytic leukemia with inv(8) chromosomal rearrangement and MOZ-NCOA2 gene fusion.

Murati A, Adélaïde J, Popovici C, Mozziconacci MJ, Arnoulet C, Lafage-Pochitaloff M, Sainty D, Birnbaum D, Chaffanet M.

Int J Mol Med. 2003 Oct;12(4):423-8.

PMID:
12964013
Items per page

Supplemental Content

Write to the Help Desk